✦ LIBER ✦

Plasmapheresis in multiple sclerosis

✍ Scribed by Bruce C. McLeod

Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 64 KB
Volume: 18
Category: Article
ISSN: 0733-2459
DOI: 10.1002/jca.10058

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Plasmapheresis in chronic progressive mu

Plasmapheresis in chronic progressive multiple sclerosis: Pro

✍ Michael P. McQuillen 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB

Plasmapheresis in acute multiple scleros

Plasmapheresis in acute multiple sclerosis: Rationale and results

✍ Peter C. Dau 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 557 KB

Acute multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS). As listed in Table I, the lesions (plaques) are infiltrated first by perivascular and then by parenchymal T lymphocytes with a CD4' over CD8' cell type pre-Address reprint requests to

Plasmapheresis in acute attacks of multi

Plasmapheresis in acute attacks of multiple sclerosis: The cons

✍ Dr. A. M. Rostami 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB

Plasmapheresis as a treatment for multiple sclerosis (MS) has been a subject of controversy since its original use in this disorder in 1979 11-31. The rationale for the use of plasmapheresis is that MS presumably is an autoimmune disease with evidence for the presence of anti-myelin antibodies 14-61

Plasmapheresis in amyotrophic lateral sc

Plasmapheresis in amyotrophic lateral sclerosis

✍ Marcelo R. Olarte; Richard S. Schoenfeldt; Glynis McKiernan; Lewis P. Rowland 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB 👁 2 views

Plasmapheresis combined with interferon:

Plasmapheresis combined with interferon: An effective therapy for multiple sclerosis

✍ Rajko D. Medenica; Sonjoy Mukerjee; Kenneth Alonso; Gavrilo Lazovic; Teresa Husc 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 593 KB

The rationale for the use of interferon (IFN) in the treatment of multiple sclerosis (MS) is based on its recognized antiviral and irnmunomodulating actions. The pathogenesis of MS is believed to be due to an immunologic response in a genetically predisposed individual, localized within the central

Interferon inhibitor factor predicting s

Interferon inhibitor factor predicting success of plasmapheresis in patients with multiple sclerosis

✍ Rajko D. Medenica; Sonjoy Mukerjee; Teresa Huschart; Wendy Corbitt 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 741 KB

Interferons (IFN) are biological molecules with antiviral, antiproliferative, and immunomodulatory actions. Plasmapheresis (PP) combined with IFN therapy in 24 multiple sclerosis (MS) patients was associated with a rapid increase in detectable IFN levels. We describe the presence of a detectable fac